David Saxon

Q: What is David Saxon's success rate?

David Saxon currently has a success rate of 93.17334530014996.

Q: What is the average return of David Saxon's calls?

Their stock ratings have generated an average return of 11.826123506470319.

Needham | Healthcare

David Saxon is an analyst from Needham specializing in the Healthcare sector. Ranked #1767 out of 4489 analysts, they have issued 68 stock ratings with a success rate of 93.17% and an average return of 11.83%.

David Saxon has a well-established track record, with 68 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 93.17% and an average return of 11.83%, underscoring their expertise and ability to identify winning opportunities for investors.

#1767

Out of 4489

Total Ratings

+93.17%

Success Rate

+11.83%

Average Return

Recent Ratings Analysis

AZTA

Buy

Dec 19, 2025

Target

$44.00

Current

$34.43

Performance

0.00%

David Saxon rated AZTA as Buy on Dec 19, 2025, setting a price target of 44. Shares have remained stable near 34.43, leaving the 44 target still in play.

SIBN

Buy

Dec 16, 2025

Target

$27.00

Current

$20.38

Performance

4.94%

On Dec 16, 2025, SIBN was given a Buy rating by David Saxon, with a target price of 27. The stock traded sideways with a 4.94% move, keeping the bullish thesis unresolved.

GKOS

Buy

Dec 09, 2025

Target

$125.00

Current

$116.22

Performance

8.75%

GKOS received a Buy rating from David Saxon on Dec 09, 2025, aiming for 125. Momentum has favored the Buy call, with shares climbing from 116.22 to 116.22, rewarding those who trusted the recommendation.

COO

Buy

Dec 05, 2025

Target

$100.00

Current

$82.75

Performance

1.66%

On Dec 05, 2025, David Saxon published a Buy outlook on COO, with a target of 100. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 82.75.

ALC

Buy

Nov 12, 2025

Target

$98.00

Current

$79.97

Performance

0.67%

David Saxon on Nov 12, 2025 assigned ALC a Buy rating, with a price target of 98. The recommendation remains pending validation as shares consolidate around 79.97.

RXST

Buy

Nov 06, 2025

Target

$12.00

Current

$12.03

Performance

39.72%

On Nov 06, 2025, David Saxon reaffirmed RXST with a Buy rating, targeting 12. The recommendation was supported by strong follow-through as the stock rose from 12.03 to 12.03.

CYRX

Buy

Nov 05, 2025

Target

$12.00

Current

$9.42

Performance

10.43%

CYRX was rated Buy by David Saxon on Nov 05, 2025, with a price objective of 12. A bullish response from the market helped close the gap of 2.58 to the target.

ATEC

Buy

Oct 31, 2025

Target

$22.00

Current

$20.01

Performance

5.37%

On Oct 31, 2025, David Saxon initiated coverage on ATEC with a Buy rating and target of 22. The stock’s climb of 5.37% since the call highlights the foresight in the rating.

IRTC

Buy

Oct 31, 2025

Target

$244.00

Current

$174.17

Performance

-7.01%

David Saxon issued a Buy recommendation for IRTC on Oct 31, 2025, price target set at 244. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

XRAY

Hold

Sep 26, 2025

Target

$0.00

Current

$11.21

Performance

-10.32%

On Sep 26, 2025, XRAY was evaluated by David Saxon, who gave a Hold rating and target of null. The Hold call avoided chasing into subsequent weakness of 10.32%.

SGHT

Hold

Aug 28, 2025

Target

$0.00

Current

$8.45

Performance

109.16%

David Saxon rated SGHT as Hold on Aug 28, 2025, setting a price target of null. Despite the Hold call, shares climbed 109.16% to 8.45, revealing unexpected momentum.

GMED

Hold

Jul 21, 2025

Target

$0.00

Current

$87.06

Performance

67.78%

On Jul 21, 2025, GMED was given a Hold rating by David Saxon, with a target price of null. The stock rallied from 87.06 to 87.06 after the Hold rating, surprising to the upside.

ZIMV

Hold

Apr 09, 2025

Target

$0.00

Current

$18.99

Performance

97.81%

ZIMV received a Hold rating from David Saxon on Apr 09, 2025, aiming for null. Investors saw gains of 97.81% that the cautious stance didn’t fully capture.

NVST

Hold

Mar 06, 2025

Target

$0.00

Current

$22.28

Performance

24.96%

On Mar 06, 2025, David Saxon published a Hold outlook on NVST, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

STAA

Hold

Feb 27, 2025

Target

$0.00

Current

$25.14

Performance

42.11%

David Saxon on Feb 27, 2025 assigned STAA a Hold rating, with a price target of null. Shares outperformed expectations, climbing 42.11% despite the neutral view.

BLCO

Hold

Feb 20, 2025

Target

$0.00

Current

$16.98

Performance

6.86%

On Feb 20, 2025, David Saxon reaffirmed BLCO with a Hold rating, targeting null. Market strength beyond 16.98 went further than the conservative outlook suggested.

ALGN

Hold

Feb 06, 2025

Target

$0.00

Current

$157.69

Performance

-27.79%

ALGN was rated Hold by David Saxon on Feb 06, 2025, with a price objective of null. Investors who stayed cautious avoided some of the 27.79% decline.

Frequency Asked Questions

Who is David Saxon?

David Saxon is an analyst from Needham specializing in the Healthcare sector.

What is David Saxon's success rate?

David Saxon currently has a success rate of +93.17%.

How many ratings has David Saxon issued?

David Saxon has issued 68 stock ratings so far.

What is the average return of David Saxon's calls?

Their stock ratings have generated an average return of +11.83%.

What is David Saxon's ranking?

David Saxon is ranked #1767 out of 4489 analysts.

What types of ratings does David Saxon give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Saxon?

You can follow David Saxon by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Saxon?

Their latest rating was a Buy on AZTA issued on 2025-12-19.